AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Phase IIa Clinical Trial of Monoclonal Antibody Initiated.(Brief Article)
2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc. (ABGX), Fremont, California, announced the start of a Phase IIa multi-center clinical trial of ABX-IL8 in patients with rheumatoid arthritis.
The company is also conducting a Phase IIa clinical trial with ABX-IL8 in patients with moderate-to-severe psoriasis, and expects to report results of this study in the first quarter of 2001.
R. Scott Greer, Abgenix, stated, "ABX-IL8 is the first fully human antibody created using our XenoMouse technology, and we hope to broaden the number of patients who could benefit from this promising new therapy."
The Phase IIa trial is a double-blind, placebo-controlled study designed to evaluate the efficacy and safety of ABX-IL8 in rheumatoid arthritis. A total of 132 patients across 20 clinical sites in the U.S. will participate in the study.
Patients will receive a total of four doses of ABX-IL8 every three weeks ...
- Phase IIa Clinical Trial Results for Pralnacasan in Rheumatoid Arthritis...
- Press release article from: PR Newswire October 29, 2002 700+ words
NEW ORLEANS -- The results of a Phase IIa rheumatoid arthritis (RA) clinical trial of pralnacasan (HMR3480...as other inflammatory diseases. The pralnacasan Phase IIa clinical trial results suggest that it may be possible...
- Incyte's JAK Inhibitor Demonstrates Marked Clinical Benefits in Phase IIa...
- Press release article from: Business Wire June 12, 2008 700+ words
...clinical results from a 28-day Phase IIa trial of INCB18424, its orally...inhibitor, in patients with rheumatoid arthritis (RA). Results from the first...remaining treatment groups in this Phase IIa trial and to describing these results...
- Arakis Announces Start of Phase IIa Trial for Rheumatoid Arthritis Drug Under...
- Press release article from: PR Newswire June 8, 2004 700+ words
...the emerging European specialty pharmaceutical company, announced today that it has initiated a Phase IIa clinical trial in 96 rheumatoid arthritis (RA) patients to study the pharmacokinetics, safety and tolerability of a range of doses of...
- Phase IIa trial starts for rheumatoid arthritis drug.
- Newspaper article from: Biotech Business Week July 5, 2004 700+ words
2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Arakis, Ltd., has initiated a phase IIa clinical trial in 96 rheumatoid arthritis (RA) patients to study the pharmacokinetics, safety and tolerability of a range of doses of...
- Merrimack Pharmaceuticals Completes Enrollment for Phase IIa Study of MM-093 in...
- Press release article from: PR Newswire August 25, 2004 700+ words
...completion of enrollment for a Phase IIa pilot study in patients with rheumatoid arthritis with its immunomodulatory...placebo-controlled, Phase IIa study is on- going at...tolerability of MM-093 in rheumatoid arthritis patients. Each patient...
- Abgenix Initiates Phase IIa Clinical Trial With ABX-IL8 For Patients With...
- Press release article from: PR Newswire December 28, 2000 700+ words
...the start of a Phase IIa multi-center...patients with rheumatoid arthritis. The company is also conducting a Phase IIa clinical trial...therapy." The Phase IIa trial is a double...ABX-IL8 in rheumatoid arthritis. A total of...
- Phase IIa clinical trial results for pralnacasan in presented at ACR.
- Newspaper article from: Biotech Week December 18, 2002 700+ words
...com & NewsRx.net) -- The results of a phase IIa rheumatoid arthritis (RA) clinical trial of pralnacasan (HMR3480...as other inflammatory diseases. The pralnacasan phase IIa clinical trial results suggest that it may be possible...
- Disappointing phase IIa clinical trial results reported for oral asthma drug.
- Newspaper article from: Genomics & Genetics Weekly February 13, 2004 700+ words
...company, announced top-line results from its phase IIa clinical trial for asthma using NGD 2000-1...In the year ahead, we expect results of our phase IIa studies in rheumatoid arthritis and further phase I results from Pfizer on our...
Source: HighBeam Research, Phase IIa Clinical Trial of Monoclonal Antibody Initiated.(Brief...